NCT07268677 2025-12-08
A Single-arm Clinical Study Evaluating Pirfenidone and Sintilimab in Combination With Standard Neoadjuvant Chemotherapy for Colorectal Cancer Patients With Peritoneal Metastasis.
Fudan University
Phase 2 Not yet recruiting
Clinical Trials
8 trialsNCT05704166 2025-08-08
PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
Fujian Medical University Union Hospital
Phase 2 Recruiting
NCT04243837 2024-04-23
LYT-100 in Patients With BCRL
PureTech
Phase 2 Terminated
NCT05801133 2024-03-15
Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors
Hubei Cancer Hospital
Phase 2 Recruiting
NCT06142318 2023-11-21
Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University
Phase 2 Unknown
NCT00076102 2018-04-23
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00332033 2017-07-02
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00754780 2012-03-19
Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1
Mayo Clinic
Phase 2 Completed